Alterations in the uterine cervix in women taken care of in a Basic Health Unit in Campinas-SP

• Autor(a) principal: Santos, Jaqueline de Oliveira
• Data de Publicação: 2007
• Outros Autores: Silva, Sueli Riul da, Santos, Celina Fernanda dos, Araújo, Madalena C. S., Bueno, Sueli Dias
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Reme (Online)
• Texto Completo: https://periodicos.ufmg.br/index.php/reme/article/view/50656
• topic: Uterine Cervical Neoplasm; Vaginal Smears; Neoplasias del Cuello Uterino; Frotis Vaginal; Neoplasias do Colo Uterino; Esfregaço Vaginal

This is a quantitative, retrospective-exploratory study with the aim of identifying the frequency of alterations in the uterine cervix and the profile of the women with altered results in the oncotic colpocytology examination in a Basic Health Unitin Campinas, in São Paulo. Data collection was carried out by an analysis of the medical register of the women who showed alterations in examinations during 2004, using a questionnaire as an instrument to collect data. The information gathered was transferred to a spread sheet of the Epi-info program, for compilation and analysis of descriptive statistics. In 2004, there were 1982 examinations, of which 24.7% showed alterations.433 medical registers were analyzed, where 47.8% of the women were under the age of 30, and the majority (61,5%) initiated their sexual activity before the age of 18;52.9% used hormone contraceptives and only 12.8% reported the use of condoms. The main alterations found were bacterial vaginosis caused by the Gardnerella vaginalis; 52.9%, candidiasis caused by the Candida sp in 15,0% and Cocobacilos in 15,5%. The presence of cervical intraepithelial neoplasm grade I associated with the HPV emerged in 1,8% of medical registers and only 0,7% had NIC in more advanced grades. These data are useful in planning strategies for the primary prevention of local cervical cancer. The elaboration and the promotion of education and surveillance programs in this population is important, in order to reduce morbidity and mortality due to uterine neoplasms.